MedPath

Docetax

Brand Name: Docetax

Generic Name: Docetaxel

Active
Registration Number

DR-XY40211

Dosage Form

Concentrate Solution for IV Infusion

Issuance Date

June 15, 2024

Expiry Date

October 19, 2029

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength40 mg/mL (80 mg/2 mL)
PackagingBox of 1-Type I hydrolytic glass vial with grey bromobutyl elastomer rubber stopper and violet flip off metal cap x 2 mL + Type I hydrolytic glass vial x 6 mL water for injection (as diluent)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Antineoplastic
A
Application
Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

DocetaxelActive
Monograph: Docetaxel

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform